Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009217
Chunk: 85

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 85
---
 not be entitled to receive any dividend or any other distribution out of the profits of the Company including, without limitation,
any allotment (whether or not fully paid) as a result of the capitalisation of any sum standing to the credit of any share premium account
or of any reserve (whether or not available for distribution) of the Company;

| (B) | As             
 regards voting |

The holders of the B Deferred Shares
shall not be entitled to receive notice of or to attend or speak (either personally or by proxy) at any general meeting of the Company
or to vote (either personally or by proxy) on any resolution to be proposed at any general meeting of the Company and shall be deemed
by virtue of the passing of the resolution adopting these Articles to have irrevocably agreed to any purchase, cancellation and extinguishment
of the B Deferred Shares pursuant to Articles 144.2 and 144.3 below;

| (C) | As              
 regards capital |

The holders of B Deferred Shares
shall on a return of capital in a liquidation, but not otherwise, be entitled to receive the nominal amount paid up or credited as paid
up on such share but only after the holder of each Ordinary Share shall have received (in cash or specie) the amount paid up or credited
as paid up on such Ordinary Share together with an additional payment of £100 per Ordinary Share and the holders of B Deferred
Shares shall be not entitled to any further or other right of participation in the assets or profits of the Company whatsoever;

| (D) | As                          
 regards variation of rights |

| (1) | The rights attached to the B Deferred Shares shall not be deemed to be varied or abrogated by the creation 
 or issue of any new shares ranking in priority to or pari passu with or subsequent to such shares; and     |

| (2) | Neither |

| (a) | the passing by the Company of any resolution for the cancellation of the B Deferred                                                     
 Shares (whether for no consideration or otherwise) by means of a reduction of capital (whether or not requiring the confirmation of the 
 Court) nor the obtaining by the Company nor the making by the Court of any order confirming any such reduction of capital nor any such  
 order becoming effective; nor                                                                                                           |

| 67 |

| (b) | the purchase by the Company in accordance with the Act of any of its own shares 
 or securities (or the passing of a resolution to permit any such purchase); nor |

| (